Each filer's latest filing for 86150R107 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
|
RTW Investments, LP
13G/A
|
9.9% |
11/16/2026
Event 9/30/2026
|
||
| RTW Investments, LP | 9.9% | |||
| Roderick Wong | 9.9% | |||
|
FMR LLC
13G/A
|
7.5% |
11/5/2026
Event 9/30/2026
|
||
| FMR LLC | 7.5% | |||
| Abigail P. Johnson | 7.5% | |||
|
Wellington Management Group LLP
13G/A
|
7.3% |
11/16/2026
Event 9/30/2026
|
||
| Wellington Management Group LLP | 7.3% | |||
| Wellington Group Holdings LLP | 7.3% | |||
| Wellington Investment Advisors Holdings LLP | 7.3% | |||
| Wellington Management Company LLP | 7.1% | |||
| BlackRock, Inc. 13G/A | 6.8% |
10/17/2025
Event 9/30/2025
|
||
|
Redmile Group, LLC
13G/A
|
6.7% |
5/15/2026
Event 3/31/2026
|
||
| Redmile Group, LLC | 6.7% | |||
| Jeremy C. Green | 6.7% | |||
| Redmile Biopharma Investments III, L.P. | 5.6% | |||
|
Lynx1 Capital Management LP
13G/A
|
6.5% |
8/14/2026
Event 6/30/2026
|
||
| Lynx1 Capital Management LP | 6.5% | |||
| Weston Nichols | 6.5% | |||
|
Biotechnology Value Fund L P
13G
|
5.6% |
9/30/2026
Event 9/23/2026
|
||
| Biotechnology Value Fund L P | 2.9% | |||
| BVF I GP LLC | 2.9% | |||
| Biotechnology Value Fund II LP | 2.2% | |||
| BVF II GP LLC | 2.2% | |||
| Biotechnology Value Trading Fund OS LP | 0.4% | |||
| BVF Partners OS Ltd. | 0.4% | |||
| BVF GP Holdings LLC | 5.1% | |||
| BVF Partners L P/IL | 5.6% | |||
| BVF Inc/IL | 5.6% | |||
| Lampert Mark N | 5.6% | |||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (7) | ||||
|
Morgan Stanley
13G/A
|
4.9% |
11/13/2026
Event 9/30/2026
|
||
| Morgan Stanley | 4.9% | |||
| Morgan Stanley Capital Services LLC | 4.1% | |||
|
Toronto Dominion Bank
13G/A
|
4.9% |
8/12/2026
Event 6/30/2026
|
||
| The Toronto-Dominion Bank | 4.9% | |||
| TD Securities Inc. | 0% | |||
|
Baker Bros. Advisors LP
13G/A
|
4.7% |
11/16/2026
Event 9/30/2026
|
||
| Baker Bros. Advisors LP | 4.7% | |||
| Baker Bros. Advisors (GP) LLC | 4.7% | |||
| Julian C. Baker | 4.7% | |||
| Felix J. Baker | 4.7% | |||
| BlackRock Portfolio Management LLC 13G/A | 4.7% |
7/15/2025
Event 6/30/2025
|
||
|
Skorpios Trust
13D/A
|
4.1% |
8/26/2025
Event 8/22/2025
|
||
| Blue Horizon Enterprise Ltd | 3.6% | |||
| Ezbon International Ltd | 0.5% | |||
| Montrago Trustees Ltd | 4.1% | |||
| Skorpios Trust | 4.1% | |||
| Cowen Financial Products LLC 13G/A | 0% |
11/14/2025
Event 9/30/2025
|
||
| Vanguard Group Inc 13G/A | 0% |
3/27/2026
Event 3/13/2026
|
||
| Period | Filers | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 185 | 73.7 M | $1.92B |
| 2026 Q2 | 198 | 76.2 M | $2.49B |
| 2026 Q1 | 198 | 71.1 M | $2.31B |
| 2025 Q4 | 186 | 67.0 M | $2.13B |
| 2025 Q3 | 154 | 67.7 M | $1.57B |
| 2025 Q2 | 135 | 65.5 M | $744M |
| 2025 Q1 | 127 | 63.4 M | $422M |
| 2024 Q4 | 131 | 58.1 M | $640M |
| 2024 Q3 | 120 | 58.2 M | $715M |
| 2024 Q2 | 117 | 61.3 M | $829M |
| 2024 Q1 | 107 | 54.2 M | $732M |
| 2023 Q4 | 82 | 45.0 M | $237M |
| 2023 Q3 | 99 | 43.9 M | $173M |
| 2023 Q2 | 101 | 46.5 M | $495M |
| 2023 Q1 | 98 | 44.6 M | $372M |
| 2022 Q4 | 108 | 40.3 M | $372M |
| 2022 Q3 | 108 | 42.3 M | $544M |
| 2022 Q2 | 96 | 43.1 M | $569M |
| 2022 Q1 | 102 | 41.4 M | $871M |
| 2021 Q4 | 96 | 35.4 M | $855M |
| 2021 Q3 | 90 | 19.4 M | $492M |
| 2021 Q2 | 98 | 20.2 M | $680M |
| 2021 Q1 | 107 | 38.4 M | $1.49B |
| 2020 Q4 | 96 | 38.6 M | $2.39B |
| 2020 Q3 | 90 | 34.6 M | $1.16B |
| 2020 Q2 | 72 | 34.9 M | $825M |
| 2020 Q1 | 68 | 34.6 M | $791M |
| 2019 Q4 | 65 | 33.5 M | $948M |
| 2019 Q3 | 54 | 15.9 M | $339M |
| 2019 Q2 | 48 | 14.2 M | $409M |